Reviews:
Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo
Metrics: PDF 2730 views | HTML 54506 views | ?
Abstract
Chinthalapally V. Rao1, Sanya Pal1, Altaf Mohammed1, Mudassir Farooqui1, Mark P. Doescher2, Adam S. Asch3 and Hiroshi Y. Yamada1
1Center for Cancer Prevention and Drug Development, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA
2Stephenson Cancer Center and Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA
3Stephenson Cancer Center, Department of Medicine, Hematology/Oncology Section, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, USA
Correspondence to:
Hiroshi Y. Yamada, email: [email protected]
Chinthalapally. V. Rao, email: [email protected]
Keywords: arsenic, reactive oxygen species (ROS), genomic instability, antioxidants, cancer prevention
Received: March 10, 2017 Accepted: April 27, 2017 Published: May 10, 2017
ABSTRACT
Through contaminated diet, water, and other forms of environmental exposure, arsenic affects human health. There are many U.S. and worldwide “hot spots” where the arsenic level in public water exceeds the maximum exposure limit. The biological effects of chronic arsenic exposure include generation of reactive oxygen species (ROS), leading to oxidative stress and DNA damage, epigenetic DNA modification, induction of genomic instability, and inflammation and immunomodulation, all of which can initiate carcinogenesis. High arsenic exposure is epidemiologically associated with skin, lung, bladder, liver, kidney and pancreatic cancer, and cardiovascular, neuronal, and other diseases. This review briefly summarizes the biological effects of arsenic exposure and epidemiological cancer studies worldwide, and provides an overview for emerging rodent-based studies of reagents that can ameliorate the effects of arsenic exposure in vivo. These reagents may be translated to human populations for disease prevention. We propose the importance of developing a biomarker-based precision prevention approach for the health issues associated with arsenic exposure that affects millions of people worldwide.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17745